Who Paid My Doc
Symbia_Intevo_Bold
Device MI - Nuclear Medicine (incl. PETNET & MIBR)
PDI 04056869044798
General payments
$2,638,089
Research payments
$195,457
Through program year 2025, $2,638,089 in general payments and $195,457 in research payments were reported against Symbia_Intevo_Bold (MI - Nuclear Medicine (incl. PETNET & MIBR)).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $2,435 | 2 |
| 2025 | Research | $755 | 6 |
| 2024 | General | $1,285,404 | 5 |
| 2024 | Research | $24,864 | 3 |
| 2023 | General | $1,349,601 | 11 |
| 2023 | Research | $112,490 | 7 |
| 2022 | General | $649 | 12 |
| 2022 | Research | $45,936 | 4 |
| 2021 | Research | $11,412 | 3 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
30 general · 23 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.